Welcome to the all-new Vetlearn

  • Exciting News Coming to Vetlearn in August 2014!
    Coming soon you'll be able to access...
  • Nearly 5,000 Compendium and Veterinary
  • Thousands of industry Conference Proceedings
  • All-new articles (CE and other topics) for the
    entire healthcare team
  • Over 500 hours of interactive CE Videos
  • An engaging new community for asking
    questions, making connections and more!

To access Vetlearn, you must first sign in or register.


  • Registration for new subscribers will open in August 2014!
  • Watch for additional exciting news coming soon!
Become a Member

Compendium September 2009 (Vol 31, No 9)

Canine Cushing's Treatment

by Mitch Potter, DVM, Gayle Trotter

    Vetoryl capsules, manufactured by Dechra, contain the drug trilostane, which has been demonstrated to be effective in the treatment of Cushing's syndrome in dogs. Dechra has just received FDA approval to market 10-mg Vetoryl capsules in addition to the 30-mg and 60-mg sizes. Vetoryl is the only FDA-approved product that is indicated for use in pituitary-dependent and adrenal-dependent hyperadrenocorticism in dogs. The 10-mg capsules will be available from distributors shortly.
    Dechra Veterinary Products

    NEXT: Client Handout — Feline Senior Wellness


    Did you know... ELISA and other immunochromatographic tests are the preferred screening tests for feline leukemia and feline immunodeficiency virus.Read More

    These Care Guides are written to help your clients understand common conditions. They are formatted to print and give to your clients for their information.

    Stay on top of all our latest content — sign up for the Vetlearn newsletters.
    • More